Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis

Juan Xiao, Rongbing Yang, Sangita Biswas, Xin Qin, Min Zhang, Wenbin Deng

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Multiple sclerosis (MS) is a chronic, autoimmune, inflammatory demyelinating disorder of the central nervous system that leads to permanent neurological deficits. Current MS treatment regimens are insufficient to treat the irreversible neurological disabilities. Tremendous progress in the experimental and clinical applications of cell-based therapies has recognized stem cells as potential candidates for regenerative therapy for many neurodegenerative disorders including MS. Mesenchymal stem cells (MSC) and induced pluripotent stem cell (iPSCs) derived precursor cells can modulate the autoimmune response in the central nervous system (CNS) and promote endogenous remyelination and repair process in animal models. This review highlights studies involving the immunomodulatory and regenerative effects of mesenchymal stem cells and iPSCs derived cells in animal models, and their translation into immunomodulatory and neuroregenerative treatment strategies for MS.

Original languageEnglish (US)
Pages (from-to)9283-9302
Number of pages20
JournalInternational Journal of Molecular Sciences
Issue number5
StatePublished - Apr 24 2015


  • Induced pluripotent stem cells
  • Mesenchymal stem cells
  • Multiple sclerosis
  • Neural stem cell

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications


Dive into the research topics of 'Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis'. Together they form a unique fingerprint.

Cite this